三维高分辨率延迟强化序列评估Fontan循环儿童青少年肝纤维化
回顾性研究评估了35例Fontan循环儿童青少年在15-20分钟延迟3D高分辨率 late gadolinium enhancement (3D HR LGE) 序列上的异常肝强化,并与35例修复法洛四联症患者比较。66%的Fontan患者总肝强化评分>0,且右叶受累更明显;强化程度与门静脉血流呈负相关、与左叶硬度呈正相关。结论认为3D HR LGE可用于评估Fontan循环患者的肝纤维化。
要点
- Fontan循环儿童青少年中66%在15-20分钟延迟3D HR LGE出现异常肝强化,提示肝纤维化。
- 异常强化右叶更明显,且与门静脉血流减少、左叶硬度增加相关。
- 延迟3D HR LGE强化评分在5-7分钟至15-20分钟延迟期有37%患者下降。
关键影像表现/征象
- Fontan组23/35(66%)患者总肝强化评分>0(范围0-5),右叶受累更明显(评分1 (0-1) vs 0 (0-1),p<0.01)。
- 修复法洛四联症组未见异常肝强化。
- Fontan组总肝强化评分在早期门静脉期为3 (2-4),5-7分钟延迟期降至1 (1-2)(p<0.01),15-20分钟延迟期最低为1 (0-2)(p=0.03)。
- 3D HR LGE强化与门静脉血流呈负相关(rs=-0.42,p=0.01),与左叶硬度呈正相关(rs=0.51,p<0.01)。
- 13/35(37%)患者强化评分从5-7分钟延迟期至15-20分钟延迟期下降。
诊断标准与关键数值
- 肝异常强化按叶分级(0-3分),两叶相加为总肝强化评分(0-6分)。
临床应用与阅片要点
- 在Fontan循环儿童青少年中,15-20分钟延迟3D HR LGE出现肝异常强化提示肝纤维化,应注意右叶更易受累。
- 强化程度与门静脉血流减少和左叶硬度增加相关,可结合这些影像生物标志物综合评估。
- 强化评分随时间延迟可能下降,判读时需注意延迟时间对评分的影响。
局限性
- 回顾性研究,样本量有限(Fontan组35例,对照组35例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To assess abnormal liver enhancement on 15-20 min delayed 3D high-resolution late gadolinium enhancement (3D HR LGE) sequence in patients with Fontan circulation.
METHODS: Retrospective study of pediatric Fontan patients (< 18 years old) with combined cardiac-liver MRI from January 2018 to August 2021. Abnormal hepatic enhancement was graded (0-3) for each lobe, summed for a total liver enhancement score (0-6), and compared to repaired tetralogy of Fallot (rTOF) patients. Correlations with other hepatic imaging biomarkers were performed. Temporal relationships of enhancement compared to traditional early portal venous and 5-7-min delayed phase liver imaging were analyzed.
RESULTS: The Fontan group (n = 35, 13 ± 3.4 years old, median time from Fontan 10 (9-12) years) had 23/35 (66%) with delayed 3D HR LGE total liver enhancement score > 0 (range 0-5), with greater involvement of the right lobe (1 (0-1) vs 0 (0-1), p < 0.01). The rTOF group (n = 35, 14 ± 2.6 years old) had no abnormal enhancement. In the Fontan group, total liver enhancement was 3 (2-4) in the early portal venous phase, lower at 1 (1-2) in the 5-7-min delayed phase (p < 0.01), and lowest at 1 (0-2) in the 15-20-min delayed phase (p = 0.03). 3D HR LGE enhancement correlated inversely with portal vein flow (rs = - 0.42, p = 0.01) and positively with left lobe stiffness (rs = 0.51, p < 0.01). The enhancement score decreased in 13/35 (37%) between the 5-7- and 15-20-min delayed phases.
CONCLUSIONS: Liver fibrosis can be assessed on 3D HR LGE sequences in patients with Fontan circulation, correlates with other imaging biomarkers of Fontan liver disease, and may add information for hepatic surveillance in this population.
KEY POINTS: • Abnormal liver enhancement on 3D HR LGE sequences in Fontan patients likely represents liver fibrosis and is seen in up to 66% of children and adolescents with variable distribution and severity. • The degree of 3D HR LGE liver enhancement correlates with decreased portal vein flow and increased left hepatic lobe stiffness.
引用
- Acosta Izquierdo, Rai, Saprungruang, et al. Assessment of liver fibrosis using a 3-dimensional high-resolution late gadolinium enhancement sequence in children and adolescents with Fontan circulation. Eur Radiol. 2023. PMID: 36786904. doi:10.1007/s00330-023-09452-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。